SLC5A2 and type 2 diabetes mellitus: Therefore, this study aimed to evaluate the efficacy and safety of combining SGLT2 inhibitors with conventional intensive insulin therapy in hospitalised patients with T2DM who presented with severe hyperglycaemia.